-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Severe acute pancreatitis (SAP) is a serious inflammatory disease with high mortality.
A retrospective study on the clinical efficacy of 130 SAP patients.
The results showed that the mortality and WBC counts of the 400,000 IU and 600,000 IU groups were significantly lower than those of the 200,000 IU group (P<0.
In summary, the results of this study show that Ulinastatin can improve the clinical outcome of SAP patients, but the efficacy varies with different doses.
Original source:
Hai Wang He, Hong Zhang.
ncbi.
nlm.
nih.
gov/32312068/" target="_blank" rel="noopener">The efficacy of different doses of ulinastatin in the treatment of severe acute pancreatitis in this message